Investor insights
Countries invested in
Sectors invested in
Funding rounds participated in
$25M sweet spot round size
Most of their 84 investments are in rounds between $13M and $47M
Investor type
Basic info
Industry
Sectors
Date founded
2007
Investments made
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $53M on April 27, 2023
Investors: GV, Canaan, Adjuvant Capital, Sofinnova Ventures, Russia technology fund, BioImpact Capital and Lumira Ventures
Cardiac Dimensions raised $35M on January 5, 2023
Investors: EQT Growth and Lumira Ventures
HistoSonics, Inc. raised $85M on December 13, 2022
Investors: Venture Investors, State of Wisconsin Investment Board and Lumira Ventures
PIC Therapeutics raised $35M on October 19, 2022
Investors: Advent Life Sciences, OrbiMed Advisors, Harrington Discovery Institute at University Hospitals and Lumira Ventures
X4 Pharmaceuticals raised $55M on June 30, 2022
Investors: Hercules Capital, Inc., AXA Investment Managers, Acorn Bioventures, OrbiMed Advisors and Lumira Ventures
Congruence Therapeutics raised $50M on February 8, 2022
Investors: Amplitude Ventures, OrbiMed Advisors, Driehaus Capital Management LLC and Lumira Ventures
Specific Biologics raised undisclosed on December 16, 2021
Investors: adMare BioInnovations and Lumira Ventures
OncoMyx Therapeutics raised $50M on December 9, 2021
Investors: Delos Capital, Korea Investment Partners, LYZZ CAPITAL, City Hill Ventures, Madison Partners, Xeraya Capital, B Capital Group and Lumira Ventures
Undisclosed raised $50M on December 8, 2021
Investors: Delos Capital, Korea Investment Partners, Xeraya Capital, B Capital Group, LYZZ CAPITAL, Madison Partners, City Hill Ventures and Lumira Ventures
Antios Therapeutics raised $75M on November 3, 2021
Investors: GRA Venture Fund LLC, Sixty Degree Capital, GordonMD Global Investments LP, RA Capital Management, L.P., LifeSci Venture Partners, Pontifax Venture Capital, Soleus Capital Management, L.P. and Lumira Ventures